Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 4 (2007), Issue 4 (April)

1. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.
   J Clin Oncol, 25(10): 1247-54. [Abstract] [Full-text]
2. Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology.
   J Clin Oncol, 25(10): 1176-82. [Abstract] [Full-text]
3. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
   J Clin Oncol, 25(10): 1160-8. [Abstract] [Full-text]
4. Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
   J Clin Oncol, 25(10): 1232-8. [Abstract] [Full-text]
5. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
   Ophthalmology, 114(4): 686-91. [Abstract] [Full-text]
6. Seronegative Lyme neuroborreliosis in a patient on treatment for chronic lymphatic leukemia.
   Infection, 35(2): 110-3. [Abstract] [Full-text]
7. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists.
   Obstet Gynecol, 109(4): 1007-19. [Abstract] [Full-text]
8. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?
   Clin Radiol, 62(5): 439-46. [Abstract] [Full-text]
9. Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin).
   Am J Cardiol, 99(7): 1002-5. [Abstract] [Full-text]
10. In vitro efficacy of newly designed vancomycin-based microparticles.
    J Cataract Refract Surg, 33(4): 702-8. [Abstract] [Full-text]
11. Prescribing in palliative care as death approaches.
    J Am Geriatr Soc, 55(4): 590-5. [Abstract] [Full-text]
12. Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
    J Med Virol, 79(5): 511-21. [Abstract] [Full-text]
13. A survey of antiepileptic prescribing to women of childbearing potential in psychiatry.
    Arch Womens Ment Health, 10(2): 83-5. [Abstract] [Full-text]
14. Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice.
    Pharmacoepidemiol Drug Saf, 16(4): 422-8. [Abstract] [Full-text]
15. Declining antibiotic prescriptions for upper respiratory infections, 1993-2004.
    Acad Emerg Med, 14(4): 366-9. [Abstract] [Full-text]
16. Intravenous dextrose during outpatient rehydration in pediatric gastroenteritis.
    Acad Emerg Med, 14(4): 324-30. [Abstract] [Full-text]
17. Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linker.
    Bioorg Med Chem Lett, 17(8): 2278-80. [Abstract] [Full-text]
18. A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery.
    Int J Cancer, 120(10): 2185-90. [Abstract] [Full-text]
19. Breast tumours following combined hormone replacement therapy express favourable prognostic factors.
    Int J Cancer, 120(10): 2202-7. [Abstract] [Full-text]
20. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.
    Bioorg Med Chem Lett, 17(8): 2237-40. [Abstract] [Full-text]
21. Talc mediates angiostasis in malignant pleural effusions via endostatin induction.
    Eur Respir J, 29(4): 761-9. [Abstract] [Full-text]
22. Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging.
    Int J Pharm, 335(1): 46-53. [Abstract] [Full-text]
23. Target delivery in a microfluidic immunosensor.
    Biosens Bioelectron, 22(11): 2763-7. [Abstract] [Full-text]
24. Factors influencing intestinal microparticle uptake in vivo.
    Int J Pharm, 335(1): 79-89. [Abstract] [Full-text]
25. Response to SSRIs and role of the hormonal therapy in post-menopausal depression.
    Eur Neuropsychopharmacol, 17(6): 400-5. [Abstract] [Full-text]
26. Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax.
    Eur Respir J, 29(4): 757-60. [Abstract] [Full-text]
27. The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides.
    Int J Pharm, 335(1): 176-9. [Abstract] [Full-text]
28. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
    Int J Pharm, 335(1): 167-75. [Abstract] [Full-text]
29. The combined effect of IDA and glutaraldehyde on the erythrocyte membrane proteins.
    Int J Pharm, 335(1): 154-62. [Abstract] [Full-text]
30. Low molecular weight heparin loaded pH-sensitive microparticles.
    Int J Pharm, 335(1): 147-53. [Abstract] [Full-text]
31. pH sensitive alginate-guar gum hydrogel for the controlled delivery of protein drugs.
    Int J Pharm, 335(1): 123-9. [Abstract] [Full-text]
32. In situ gelling pectin formulations for oral drug delivery at high gastric pH.
    Int J Pharm, 335(1): 90-6. [Abstract] [Full-text]
33. A new biodegradable and biocompatible hydrogel with polyaminoacid structure.
    Int J Pharm, 335(1): 130-7. [Abstract] [Full-text]
34. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
    Int J Pharm, 335(1): 114-22. [Abstract] [Full-text]
35. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion.
    Int J Pharm, 335(1): 193-202. [Abstract] [Full-text]
36. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions.
    Pharmacoepidemiol Drug Saf, 16(4): 441-8. [Abstract] [Full-text]
37. Studying co-medication patterns: the impact of definitions.
    Pharmacoepidemiol Drug Saf, 16(4): 405-11. [Abstract] [Full-text]
38. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
    Am J Obstet Gynecol, 196(4): 342.e1-9. [Abstract] [Full-text]
39. Selective imaging of adherent targeted ultrasound contrast agents.
    Phys Med Biol, 52(8): 2055-72. [Abstract] [Full-text]
40. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.
    Neurology, 68(14): 1108-15. [Abstract] [Full-text]
41. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Arch Gen Psychiatry, 64(4): 466-72. [Abstract] [Full-text]
42. The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.
    Clin Cancer Res, 13(7): 2191-8. [Abstract] [Full-text]
43. Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer.
    Clin Cancer Res, 13(7): 2061-7. [Abstract] [Full-text]
44. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.
    Am J Psychiatry, 164(4): 622-9. [Abstract] [Full-text]
45. In vivo efficacy of antimicrobial-coated devices.
    J Bone Joint Surg Am, 89(4): 792-7. [Abstract] [Full-text]
46. Medication errors in paediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations.
    Qual Saf Health Care, 16(2): 116-26. [Abstract] [Full-text]
47. Antibiotic prescribing in primary care: first choice and restrictive prescribing are two different traits.
    Qual Saf Health Care, 16(2): 105-9. [Abstract] [Full-text]
48. Implementation of a medication reconciliation process in an ambulatory internal medicine clinic.
    Qual Saf Health Care, 16(2): 90-4. [Abstract] [Full-text]
49. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Liver Int, 27(4): 548-57. [Abstract] [Full-text]
50. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Pediatrics, 119(4): e900-6. [Abstract] [Full-text]
51. Manufacturing monodisperse chitosan microparticles containing ampicillin using a microchannel chip.
    Biomed Microdevices, 9(2): 253-9. [Abstract] [Full-text]
52. Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication.
    Toxicology, 233(1): 40-6. [Abstract] [Full-text]
53. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    JAMA, 297(13): 1465-77. [Abstract] [Full-text]
54. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
    Clin Infect Dis, 44(9): 1229-34. [Abstract] [Full-text]
55. The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy.
    Curr Med Res Opin, 23(4): 803-10. [Abstract] [Full-text]
56. Onset of efficacy of tolterodine extended release in patients with overactive bladder.
    Curr Med Res Opin, 23(4): 777-81. [Abstract] [Full-text]
57. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
    J Natl Cancer Inst, 99(7): 516-25. [Abstract] [Full-text]
58. Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.
    J Natl Cancer Inst, 99(7): 506-15. [Abstract] [Full-text]
59. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.
    Proc Natl Acad Sci U S A, 104(14): 5715-21. [Abstract] [Full-text]
60. Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
    Br J Cancer, 96(7): 1043-6. [Abstract] [Full-text]
61. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing.
    Br J Cancer, 96(7): 1037-42. [Abstract] [Full-text]
62. Mitomycin C and Vinorelbine for second-line chemotherapy in NSCLC--a phase II trial.
    Br J Cancer, 96(7): 1052-6. [Abstract] [Full-text]
63. Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals.
    AIDS Behav, 11(3): 385-92. [Abstract] [Full-text]
64. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline.
    J Thorac Oncol, 2(4): 348-54. [Abstract] [Full-text]
65. Phase II trial with carboplatin and bendamustine in patients with extensive stage small-cell lung cancer.
    J Thorac Oncol, 2(4): 312-6. [Abstract] [Full-text]
66. Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC).
    J Thorac Oncol, 2(4): 299-305. [Abstract] [Full-text]
67. Influence of apoptosis and cell cycle regulator proteins on chemotherapy response and survival in stage IIIA/IIIB NSCLC patients.
    J Thorac Oncol, 2(4): 293-8. [Abstract] [Full-text]
68. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    J Thorac Oncol, 2(4): 287-92. [Abstract] [Full-text]
69. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy.
    J Thorac Oncol, 2(4): 268-72. [Abstract] [Full-text]
70. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.
    Cancer Res, 67(7): 3364-70. [Abstract] [Full-text]
71. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.
    J Dermatol, 34(5): 320-7. [Abstract] [Full-text]
72. Pulmonary vaccine delivery.
    Expert Rev Vaccines, 6(2): 213-26. [Abstract] [Full-text]
73. Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system.
    AAPS PharmSciTech, 8(1): 26. [Abstract] [Full-text]
74. Effect of selected non-ionic surfactants on the flow behavior of aqueous veegum suspensions.
    AAPS PharmSciTech, 8(1): 25. [Abstract] [Full-text]
75. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
    AAPS PharmSciTech, 8(1): 24. [Abstract] [Full-text]
76. Application of thermal effusivity as a process analytical technology tool for monitoring and control of the roller compaction process.
    AAPS PharmSciTech, 8(1): 23. [Abstract] [Full-text]
77. Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice.
    J Appl Physiol, 102(4): 1387-93. [Abstract] [Full-text]
78. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
    Blood, 109(8): 3214-8. [Abstract] [Full-text]
79. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial.
    J Thromb Thrombolysis, 23(3): 173-9. [Abstract] [Full-text]
80. Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer.
    Anticancer Drugs, 18(5): 605-10. [Abstract] [Full-text]
81. Chemoimmunotherapy in the treatment of metastatic gastric cancer.
    Anticancer Drugs, 18(5): 597-604. [Abstract] [Full-text]
82. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
    Anticancer Drugs, 18(5): 581-6. [Abstract] [Full-text]
83. The association between fluid administration and outcome following major burn: a multicenter study.
    Ann Surg, 245(4): 622-8. [Abstract] [Full-text]
84. Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.
    Ann Surg, 245(4): 583-90. [Abstract] [Full-text]
85. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
    Am J Clin Oncol, 30(2): 172-80. [Abstract] [Full-text]
86. Activity and tolerability of a combined palliative chemotherapy with mitomycin C, folinate, and 5-Fluorouracil in patients with advanced breast cancer after intensive pretreatment: a retrospective analysis.
    Am J Clin Oncol, 30(2): 139-45. [Abstract] [Full-text]
87. A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer.
    Am J Clin Oncol, 30(2): 133-8. [Abstract] [Full-text]
88. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
    Am J Clin Oncol, 30(2): 126-32. [Abstract] [Full-text]
89. Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185).
    Am J Clin Oncol, 30(2): 113-25. [Abstract] [Full-text]
90. A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.
    Am J Clin Oncol, 30(2): 101-5. [Abstract] [Full-text]
91. Impact on weight and height with the use of HAART in HIV-infected children.
    Pediatr Infect Dis J, 26(4): 334-8. [Abstract] [Full-text]
92. Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?
    Autoimmun Rev, 6(5): 315-22. [Abstract] [Full-text]
93. Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy.
    J Acquir Immune Defic Syndr, 44(5): 531-9. [Abstract] [Full-text]
94. Electrochemotherapy of Mycosis fungoides by interferon-alpha.
    Bioelectrochemistry, 70(2): 283-6. [Abstract] [Full-text]
95. The short-term administration of Ketoprofen does not decrease the effect of Pleurodesis induced by talc or Doxycycline in rabbits.
    Respir Med, 101(5): 963-8. [Abstract] [Full-text]
96. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study.
    Int J Cardiol, 117(3): 349-54. [Abstract] [Full-text]
97. Self-induced medical abortion in an adolescent.
    J Pediatr Adolesc Gynecol, 20(2): 93-5. [Abstract] [Full-text]
98. Biofilm formation in cochlear implants with cochlear drug delivery channels in an in vitro model.
    Otolaryngol Head Neck Surg, 136(4): 577-82. [Abstract] [Full-text]
99. Pediatric medication errors in the postanesthesia care unit: analysis of MEDMARX data.
    AORN J, 85(4): 731-40; quiz 741-4. [Abstract] [Full-text]
100. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
     Cancer Epidemiol Biomarkers Prev, 16(4): 723-30. [Abstract] [Full-text]
101. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
     Hum Psychopharmacol, 22(3): 173-80. [Abstract] [Full-text]
102. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
     Inorg Chem, 46(8): 3203-11. [Abstract] [Full-text]
103. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain.
     Neurosci Lett, 417(1): 50-4. [Abstract] [Full-text]
104. Postmenopausal hormone therapy and changes in mammographic density.
     J Clin Oncol, 25(11): 1323-8. [Abstract] [Full-text]
105. Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
     Vaccine, 25(17): 3277-83. [Abstract] [Full-text]
106. Self-management of oral anticoagulant therapy: a systematic review and meta-analysis.
     Int J Cardiol, 118(1): 54-61. [Abstract] [Full-text]
107. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
     Retina, 27(4): 458-61. [Abstract] [Full-text]
108. Older age and the response to and tolerability of antiretroviral therapy.
     Arch Intern Med, 167(7): 684-91. [Abstract] [Full-text]
109. Prophylaxis of acute posttraumatic bacterial endophthalmitis: a multicenter, randomized clinical trial of intraocular antibiotic injection, report 2.
     Arch Ophthalmol, 125(4): 460-5. [Abstract] [Full-text]
110. Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians.
     Arch Neurol, 64(4): 518-21. [Abstract] [Full-text]
111. Multidisciplinary approach to inpatient medication reconciliation in an academic setting.
     Am J Health Syst Pharm, 64(8): 850-4. [Abstract] [Full-text]
112. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
     Circulation, 115(14): 1876-84. [Abstract] [Full-text]
113. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
     Growth Horm IGF Res, 17(2): 149-53. [Abstract] [Full-text]
114. Recombinant activated factor VII increases survival time in a model of incompressible arterial hemorrhage in the anesthetized pig.
     J Trauma, 62(4): 868-79. [Abstract] [Full-text]
115. What is the best adjuvant treatment for very young patients with medulloblastoma?
     Expert Rev Neurother, 7(4): 373-81. [Abstract] [Full-text]
116. Use of nanoparticles for drug delivery in glioblastoma multiforme.
     Expert Rev Neurother, 7(4): 363-72. [Abstract] [Full-text]
117. Chemotherapy for advanced gastric cancer: across the years for a standard of care.
     Expert Opin Pharmacother, 8(6): 797-808. [Abstract] [Full-text]
118. Adult growth hormone deficiency: to treat or not to treat.
     Expert Opin Pharmacother, 8(6): 787-95. [Abstract] [Full-text]
119. Glucocorticoid replacement therapy in patients with Addison's disease.
     Expert Opin Pharmacother, 8(6): 725-9. [Abstract] [Full-text]
120. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
     Viral Immunol, 20(1): 180-7. [Abstract] [Full-text]
121. Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen.
     Viral Immunol, 20(1): 131-41. [Abstract] [Full-text]
122. Molecular architecture of leishmania EF-1alpha reveals a novel site that may modulate protein translation: a possible target for drug development.
     Biochem Biophys Res Commun, 356(4): 886-92. [Abstract] [Full-text]
123. Electrostatic ligand coatings of nanoparticles enable ligand-specific gene delivery to human primary cells.
     Nano Lett, 7(4): 874-9. [Abstract] [Full-text]
124. Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma.
     Expert Rev Anticancer Ther, 7(4): 551-66. [Abstract] [Full-text]
125. Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
     Expert Rev Anticancer Ther, 7(4): 503-18. [Abstract] [Full-text]
126. Bevacizumab in the management of solid tumors.
     Expert Rev Anticancer Ther, 7(4): 433-45. [Abstract] [Full-text]
127. Cetuximab plus irinotecan in refractory colorectal cancer patients.
     Expert Rev Anticancer Ther, 7(4): 407-13. [Abstract] [Full-text]
128. What psychotherapists should know about pharmacotherapies for bipolar disorder.
     J Clin Psychol, 63(5): 475-90. [Abstract] [Full-text]
129. Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells.
     Cell Mol Life Sci, 64(7): 979-88. [Abstract] [Full-text]
130. Synthesis and evaluation of ampicillin-conjugated gum arabic microspheres for sustained release.
     J Pharm Pharmacol, 59(4): 485-93. [Abstract] [Full-text]
131. pH-sensitive liposomes--principle and application in cancer therapy.
     J Pharm Pharmacol, 59(4): 469-83. [Abstract] [Full-text]
132. The role of the nurse prescriber: the views of mental health and non-mental health nurses.
     J Psychiatr Ment Health Nurs, 14(3): 258-66. [Abstract] [Full-text]
133. Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter.
     Dermatol Surg, 33(4): 469-75. [Abstract] [Full-text]
134. The effect of combining intermittent hemodiafiltration with forced alkaline diuresis on plasma myoglobin in rhabdomyolysis.
     Acta Anaesthesiol Scand, 51(5): 553-8. [Abstract] [Full-text]
135. Stroke volume variation during hemorrhage and after fluid loading: impact of different tidal volumes.
     Acta Anaesthesiol Scand, 51(5): 538-44. [Abstract] [Full-text]
136. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
     Bipolar Disord, 9(3): 252-61. [Abstract] [Full-text]
137. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005.
     BMC Womens Health, 7: 4. [Abstract] [Full-text]
138. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
     J Gene Med, 9(4): 253-64. [Abstract] [Full-text]
139. Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses.
     Clin Microbiol Infect, 13(5): 510-5. [Abstract] [Full-text]
140. Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system.
     Biochim Biophys Acta, 1768(5): 1093-102. [Abstract] [Full-text]
141. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
     Clin Microbiol Infect, 13(5): 497-503. [Abstract] [Full-text]
142. Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study.
     Fertil Steril, 87(4): 978-81. [Abstract] [Full-text]
143. Antiretroviral therapy for HIV-1-infected children in Haiti.
     J Infect Dis, 195(10): 1411-8. [Abstract] [Full-text]
144. Drug delivery methods for posterior segment disease.
     Curr Opin Ophthalmol, 18(3): 235-9. [Abstract] [Full-text]
145. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
     Acad Radiol, 14(5): 561-73. [Abstract] [Full-text]
146. Sex hormones and thrombosis.
     Semin Hematol, 44(2): 98-105. [Abstract] [Full-text]
147. Endoscopically placed caecostomy buttons: a trial ACE procedure.
     Colorectal Dis, 9(4): 373-6. [Abstract] [Full-text]
148. Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens.
     Int J Antimicrob Agents, 29(5): 544-8. [Abstract] [Full-text]
149. In vitro and in vivo effects of deoxyribonucleic acid-based coatings funtionalized with vascular endothelial growth factor.
     Tissue Eng, 13(4): 711-20. [Abstract] [Full-text]
150. Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation.
     Eur J Haematol, 78(5): 374-80. [Abstract] [Full-text]
151. Foam sclerotherapy combined with surgical treatment for recurrent varicose veins: short term results.
     Eur J Vasc Endovasc Surg, 33(5): 619-24. [Abstract] [Full-text]
152. Influence of membrane-solvent-solute interactions on solute permeation in model membranes.
     Int J Pharm, 336(1): 108-14. [Abstract] [Full-text]
153. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form.
     Int J Pharm, 336(1): 159-65. [Abstract] [Full-text]
154. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
     Int J Pharm, 336(1): 166-73. [Abstract] [Full-text]
155. Estradiol replacement in ovariectomized rats is antihyperalgesic in the formalin test.
     J Pain, 8(4): 334-42. [Abstract] [Full-text]
156. Micelle formation and drug release behavior of polypeptide graft copolymer and its mixture with polypeptide block copolymer.
     Int J Pharm, 336(1): 49-57. [Abstract] [Full-text]
157. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date.
     J Neurol Neurosurg Psychiatry, 78(5): 485-91. [Abstract] [Full-text]
158. Parental administration of analgesic medication in children after a limb injury.
     Pediatr Emerg Care, 23(4): 223-6. [Abstract] [Full-text]
159. The vital sensation of the minerals: reducing uncertainty in homeopathic prescribing.
     Homeopathy, 96(2): 102-7. [Abstract] [Full-text]
160. Outcomes from homeopathic prescribing in dental practice: a prospective, research-targeted, pilot study.
     Homeopathy, 96(2): 74-81. [Abstract] [Full-text]
161. Influence of comorbidities and medication use on tilt table test outcome in elderly patients.
     Pacing Clin Electrophysiol, 30(4): 540-3. [Abstract] [Full-text]
162. Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.
     BJU Int, 99(5): 1047-55. [Abstract] [Full-text]
163. Hodgkin's lymphoma initially presenting with polymyalgic symptoms: a case report.
     Mod Rheumatol, 17(2): 160-2. [Abstract] [Full-text]
164. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
     Int J Cancer, 120(12): 2527-37. [Abstract] [Full-text]
165. Medicine use among 11- and 13-year-olds: agreement between parents' reports and children's self-reports.
     Ann Pharmacother, 41(4): 581-6. [Abstract] [Full-text]
166. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.
     Br J Cancer, 96(8): 1166-9. [Abstract] [Full-text]
167. Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience.
     J Neurooncol, 82(3): 273-9. [Abstract] [Full-text]
168. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
     J Natl Cancer Inst, 99(8): 601-7. [Abstract] [Full-text]
169. Potential drug interactions and duplicate prescriptions among cancer patients.
     J Natl Cancer Inst, 99(8): 592-600. [Abstract] [Full-text]
170. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
     Cancer Res, 67(8): 3853-61. [Abstract] [Full-text]
171. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer.
     Cancer Res, 67(8): 3818-26. [Abstract] [Full-text]
172. Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration.
     Eur J Neurosci, 25(7): 2201-13. [Abstract] [Full-text]
173. Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.
     Eur J Neurosci, 25(7): 2191-200. [Abstract] [Full-text]
174. Two-photon absorption in tetraphenylporphycenes: are porphycenes better candidates than porphyrins for providing optimal optical properties for two-photon photodynamic therapy?
     J Am Chem Soc, 129(16): 5188-99. [Abstract] [Full-text]
175. Targeted drug delivery utilizing protein-like molecular architecture.
     J Am Chem Soc, 129(16): 4961-72. [Abstract] [Full-text]
176. Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy.
     Dig Dis Sci, 52(5): 1326-8. [Abstract] [Full-text]
177. Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma.
     Bone Marrow Transplant, 39(9): 523-7. [Abstract] [Full-text]
178. Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].
     BJOG, 114(5): 548-54. [Abstract] [Full-text]
179. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
180. Prolotherapy injections for chronic low-back pain.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
181. Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy.
     Int J Clin Oncol, 12(2): 150-4. [Abstract] [Full-text]
182. Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.
     Int J Clin Oncol, 12(2): 146-9. [Abstract] [Full-text]
183. A serious complication of thrombolysis after prolonged cardiac arrest: airway obstruction from tongue injury.
     J Cardiovasc Med (Hagerstown), 8(5): 374-6. [Abstract] [Full-text]
184. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
     J Clin Oncol, 25(12): 1545-52. [Abstract] [Full-text]
185. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
     J Clin Oncol, 25(12): 1539-44. [Abstract] [Full-text]
186. Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.
     J Clin Oncol, 25(12): 1512-8. [Abstract] [Full-text]
187. The decrease in breast-cancer incidence in 2003 in the United States.
     N Engl J Med, 356(16): 1670-4. [Abstract] [Full-text]
188. Omeprazole before endoscopy in patients with gastrointestinal bleeding.
     N Engl J Med, 356(16): 1631-40. [Abstract] [Full-text]
189. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance.
     J Control Release, 119(1): 128-35. [Abstract] [Full-text]
190. New bioerodable thermoresponsive polymers for possible radiotherapeutic applications.
     J Control Release, 119(1): 25-33. [Abstract] [Full-text]
191. A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding.
     J Control Release, 119(1): 111-20. [Abstract] [Full-text]
192. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
     J Control Release, 119(1): 41-51. [Abstract] [Full-text]
193. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
     J Control Release, 119(1): 59-68. [Abstract] [Full-text]
194. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.
     J Control Release, 119(1): 102-10. [Abstract] [Full-text]
195. Phase II study of imatinib mesylate and hydroxyurea for recurrent grade III malignant gliomas.
     J Neurooncol, 83(1): 53-60. [Abstract] [Full-text]
196. Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review.
     J Neurooncol, 83(1): 97-109. [Abstract] [Full-text]
197. Photodynamic therapy for pancreatic cancer.
     Pancreas, 34(4): 385-9. [Abstract] [Full-text]
198. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.
     Med Care, 45(5): 472-6. [Abstract] [Full-text]
199. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
     Med Care, 45(5): 456-62. [Abstract] [Full-text]
200. Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.
     J Gastroenterol Hepatol, 22(5): 738-48. [Abstract] [Full-text]
201. Induction of cytotoxic T lymphocyte response against Mycobacterial antigen using domain I of anthrax edema factor as antigen delivery system.
     Biochem Biophys Res Commun, 357(1): 50-5. [Abstract] [Full-text]
202. Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia.
     Crit Care Med, 35(5): 1341-7. [Abstract] [Full-text]
203. Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain.
     Mol Immunol, 44(12): 3112-21. [Abstract] [Full-text]
204. Microencapsulation for the improved delivery of bioactive compounds into foods.
     Curr Opin Biotechnol, 18(2): 184-90. [Abstract] [Full-text]
205. DHEA therapy for women: effect on sexual function and wellbeing.
     Hum Reprod Update, 13(3): 239-48. [Abstract] [Full-text]
206. Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation.
     Br J Ophthalmol, 91(5): 620-3. [Abstract] [Full-text]
207. Student nurses need more than maths to improve their drug calculating skills.
     Nurse Educ Today, 27(4): 278-85. [Abstract] [Full-text]
208. Why nurses make medication errors: a simulation study.
     Nurse Educ Today, 27(4): 312-7. [Abstract] [Full-text]
209. The presence of mathematics and computer anxiety in nursing students and their effects on medication dosage calculations.
     Nurse Educ Today, 27(4): 341-7. [Abstract] [Full-text]
210. Prevalence and impact of diarrhea on health-related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy.
     J Clin Gastroenterol, 41(5): 484-90. [Abstract] [Full-text]
211. The role of communication in paediatric drug safety.
     Arch Dis Child, 92(5): 440-5. [Abstract] [Full-text]
212. Successful fibrinolysis after acute left ventricular assist device thrombosis.
     J Heart Lung Transplant, 26(5): 553-5. [Abstract] [Full-text]
213. Home inotropic therapy in children.
     J Heart Lung Transplant, 26(5): 453-7. [Abstract] [Full-text]
214. Adjuvant therapy for stage II and III colorectal cancer.
     Semin Oncol, 34(2): S37-40. [Abstract] [Full-text]
215. Treatment of advanced pancreatic cancer.
     Semin Oncol, 34(2): S25-30. [Abstract] [Full-text]
216. Prevalence of postoperative complications after orthognathic surgery: a 15-year review.
     J Oral Maxillofac Surg, 65(5): 984-92. [Abstract] [Full-text]
217. Assessing postoperative discomfort after third molar surgery: a prospective study.
     J Oral Maxillofac Surg, 65(5): 901-17. [Abstract] [Full-text]
218. Coming face to face with the stenotic MACE-combined Maceoscopy and colonoscopy (the rendez-vous procedure): a preliminary report.
     J Pediatr Surg, 42(4): 685-7. [Abstract] [Full-text]
219. A new infusion syringe label system designed to reduce task complexity during drug preparation.
     Anaesthesia, 62(5): 486-91. [Abstract] [Full-text]
220. A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
     Eur J Cancer, 43(7): 1153-60. [Abstract] [Full-text]
221. Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
     Eur J Cancer, 43(7): 1171-9. [Abstract] [Full-text]
222. The proteasome: a worthwhile target for the treatment of solid tumours?
     Eur J Cancer, 43(7): 1125-33. [Abstract] [Full-text]
223. Chemoprevention of smoke-induced alopecia in mice by oral administration of L-cystine and vitamin B6.
     J Dermatol Sci, 46(3): 189-98. [Abstract] [Full-text]
224. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
     Eur J Pharm Sci, 31(1): 25-31. [Abstract] [Full-text]
225. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis.
     Antimicrob Agents Chemother, 51(5): 1661-5. [Abstract] [Full-text]
226. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
     Lung Cancer, 56(2): 247-54. [Abstract] [Full-text]
227. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
     Gynecol Oncol, 105(2): 299-303. [Abstract] [Full-text]
228. The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines.
     Gynecol Oncol, 105(2): 462-9. [Abstract] [Full-text]
229. Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
     Lung Cancer, 56(2): 263-71. [Abstract] [Full-text]
230. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
     Gynecol Oncol, 105(2): 481-92. [Abstract] [Full-text]
231. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary.
     Gynecol Oncol, 105(2): 404-8. [Abstract] [Full-text]
232. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
     Gynecol Oncol, 105(2): 399-403. [Abstract] [Full-text]
233. A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status.
     Lung Cancer, 56(2): 255-62. [Abstract] [Full-text]
234. Anticancer and chemosensitizing effects of 2,3-DCPE in ovarian carcinoma cell lines: link with ERK activation and modulation of p21WAF1/CIP1, Bcl-2 and Bcl-xL expression.
     Gynecol Oncol, 105(2): 373-84. [Abstract] [Full-text]
235. Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trial.
     Gynecol Oncol, 105(2): 358-64. [Abstract] [Full-text]
236. Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer.
     Cancer Lett, 251(1): 164-7. [Abstract] [Full-text]
237. Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol.
     Blood, 109(9): 3676-8. [Abstract] [Full-text]
238. Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.
     Blood, 109(9): 3672-5. [Abstract] [Full-text]
239. Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials.
     Blood, 109(9): 3936-44. [Abstract] [Full-text]
240. Use of continuous subcutaneous insulin infusion in patients with cystic fibrosis related diabetes: three case reports.
     J Cyst Fibros, 6(3): 237-40. [Abstract] [Full-text]
241. Modified Irinotecan/5FU/Leucovorin therapy in advanced colorectal cancer and predicting therapeutic efficacy by expression of tumor-related enzymes.
     Scand J Gastroenterol, 42(4): 477-84. [Abstract] [Full-text]
242. Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL).
     Hematology, 12(2): 149-53. [Abstract] [Full-text]
243. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
     Hematology, 12(2): 141-7. [Abstract] [Full-text]
244. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
     Climacteric, 10(2): 155-63. [Abstract] [Full-text]
245. The influence of smoking on uterine bleeding during sequential oral hormone therapy.
     Climacteric, 10(2): 147-54. [Abstract] [Full-text]
246. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
     Climacteric, 10(2): 120-31. [Abstract] [Full-text]
247. Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction.
     Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 14(3): 301-28. [Abstract] [Full-text]
248. Transsynaptic delivery of nanoparticles to the central auditory nervous system.
     Acta Otolaryngol, 127(5): 486-90. [Abstract] [Full-text]
249. The use of a cardiac output monitor to guide the initial fluid resuscitation in a patient with burns.
     Emerg Med J, 24(5): e32. [Abstract] [Full-text]
250. Recanalization after intravenous thrombolysis: does a recanalization time window exist?
     Neurology, 68(17): 1364-8. [Abstract] [Full-text]
251. A drug burden index to define the functional burden of medications in older people.
     Arch Intern Med, 167(8): 781-7. [Abstract] [Full-text]
252. The experience of massage during chemotherapy treatment in breast cancer patients.
     Clin Nurs Res, 16(2): 85-99; discussion 100-2. [Abstract] [Full-text]
253. Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy.
     Am J Ophthalmol, 143(5): 887-9. [Abstract] [Full-text]
254. Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial.
     Am Heart J, 153(5): 763-71. [Abstract] [Full-text]
255. Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.
     Am Heart J, 153(5): 749-54. [Abstract] [Full-text]
256. The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents.
     Am Heart J, 153(5): 743-8. [Abstract] [Full-text]
257. Galenics of dermal products--vehicles, properties and drug release.
     J Dtsch Dermatol Ges, 5(5): 367-83. [Abstract] [Full-text]
258. Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B.
     J Endourol, 21(4): 374-7; discussion 377. [Abstract] [Full-text]
259. Multicenter phase II study of chemo-immunotherapy in the treatment of metastatic renal cell carcinoma.
     J Immunother (1997), 30(4): 448-54. [Abstract] [Full-text]
260. Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy.
     J Immunother (1997), 30(4): 438-47. [Abstract] [Full-text]
261. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
     J Immunother (1997), 30(4): 378-95. [Abstract] [Full-text]
262. Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans.
     Cornea, 26(4): 390-7. [Abstract] [Full-text]
263. Safety of UVA-riboflavin cross-linking of the cornea.
     Cornea, 26(4): 385-9. [Abstract] [Full-text]
264. Nano- and microparticle-based imaging of cardiovascular interventions: overview.
     Radiology, 243(2): 340-7. [Abstract] [Full-text]
265. Effect of reading additional safety information on planned use of over-the-counter analgesics.
     Public Health Nurs, 24(3): 230-8. [Abstract] [Full-text]
266. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
     Biochem Biophys Res Commun, 357(2): 511-6. [Abstract] [Full-text]
267. Oral clonidine vs midazolam in the prevention of sevoflurane-induced agitation in children. a prospective, randomized, controlled trial.
     Br J Anaesth, 98(5): 667-71. [Abstract] [Full-text]
268. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.
     Leukemia, 21(5): 1005-14. [Abstract] [Full-text]
269. Strategies for suppressing angiogenesis in gynecological cancers.
     Drugs Today (Barc), 43(4): 259-73. [Abstract] [Full-text]
270. A means for targeting therapeutics to peripheral nervous system neurons with axonal damage.
     Neurosurgery, 60(5): 911-8; discussion 911-8. [Abstract] [Full-text]
271. Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis.
     Neurosurgery, 60(5): 887-94; discussion 887-94. [Abstract] [Full-text]
272. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
     J Acquir Immune Defic Syndr, 45(1): 52-9. [Abstract] [Full-text]
273. Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man.
     Onkologie, 30(5): 253-5. [Abstract] [Full-text]
274. Mitomycin C plus infusional 5-fluorouracil in platinum-refractory gastric adenocarcinoma: an extended multicenter phase II study.
     Onkologie, 30(5): 235-40. [Abstract] [Full-text]
275. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
     Onkologie, 30(5): 228-32. [Abstract] [Full-text]
276. Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.
     Invest Ophthalmol Vis Sci, 48(5): 2268-77. [Abstract] [Full-text]
277. Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy.
     Invest Ophthalmol Vis Sci, 48(5): 2254-9. [Abstract] [Full-text]
278. Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus.
     Klin Monatsbl Augenheilkd, 224(4): 353-5. [Abstract] [Full-text]
279. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.
     J Acquir Immune Defic Syndr, 45(1): 43-51. [Abstract] [Full-text]
280. CD20-specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximab.
     Cancer Immunol Immunother, 56(7): 1107-17. [Abstract] [Full-text]
281. Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans.
     Aust N Z J Psychiatry, 41(4): 366-70. [Abstract] [Full-text]
282. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
     Am J Geriatr Psychiatry, 15(5): 416-24. [Abstract] [Full-text]
283. Polypharmacy and the geriatric patient.
     Clin Geriatr Med, 23(2): 371-90, vii. [Abstract] [Full-text]
284. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
     Expert Opin Investig Drugs, 16(5): 595-604. [Abstract]